Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$8.71 - $14.65 $63,722 - $107,179
7,316 Added 609.67%
8,516 $78,000
Q4 2023

Jan 25, 2024

SELL
$7.89 - $13.14 $2,019 - $3,363
-256 Reduced 17.58%
1,200 $15,000
Q3 2023

Oct 27, 2023

BUY
$9.88 - $14.0 $14,385 - $20,384
1,456 New
1,456 $15,000
Q2 2023

Jul 18, 2023

BUY
$10.78 - $13.65 $33,008 - $41,796
3,062 Added 257.53%
4,251 $55,000
Q1 2023

Apr 13, 2023

BUY
$7.49 - $12.54 $8,905 - $14,910
1,189 New
1,189 $13,000
Q2 2022

Jul 25, 2022

SELL
$14.0 - $27.95 $1.16 Million - $2.32 Million
-83,106 Reduced 20.75%
317,499 $4.67 Million
Q1 2022

May 02, 2022

BUY
$21.13 - $35.65 $147,825 - $249,407
6,996 Added 1.78%
400,605 $9.94 Million
Q4 2021

Jan 28, 2022

BUY
$29.72 - $45.1 $11.7 Million - $17.8 Million
393,609 New
393,609 $12.6 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.